CYBERDYNE Inc. manufactures and sells medical devices in Japan. More Details
High growth potential with adequate balance sheet.
Share Price & News
How has CYBERDYNE's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 7779 is more volatile than 75% of JP stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: 7779's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of JP stocks.
7 Day Return
JP Medical Equipment
1 Year Return
JP Medical Equipment
Return vs Industry: 7779 matched the JP Medical Equipment industry which returned 19.9% over the past year.
Return vs Market: 7779 exceeded the JP Market which returned 7.3% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is CYBERDYNE's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is CYBERDYNE undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 7779 (¥666) is trading above our estimate of fair value (¥433.89)
Significantly Below Fair Value: 7779 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 7779 is poor value based on its PE Ratio (1128.2x) compared to the JP Medical Equipment industry average (26.5x).
PE vs Market: 7779 is poor value based on its PE Ratio (1128.2x) compared to the JP market (17.5x).
Price to Earnings Growth Ratio
PEG Ratio: 7779 is poor value based on its PEG Ratio (17.9x)
Price to Book Ratio
PB vs Industry: 7779 is overvalued based on its PB Ratio (3.2x) compared to the JP Medical Equipment industry average (2.2x).
How is CYBERDYNE forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7779's forecast earnings growth (62.9% per year) is above the savings rate (0%).
Earnings vs Market: 7779's earnings (62.9% per year) are forecast to grow faster than the JP market (17.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 7779's revenue (38% per year) is forecast to grow faster than the JP market (5.6% per year).
High Growth Revenue: 7779's revenue (38% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 7779's Return on Equity is forecast to be low in 3 years time (2.2%).
How has CYBERDYNE performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 7779 has a large one-off gain of ¥860.0M impacting its September 30 2020 financial results.
Growing Profit Margin: 7779 became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: 7779 has become profitable over the past 5 years, growing earnings by 24% per year.
Accelerating Growth: 7779 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 7779 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-11.4%).
Return on Equity
High ROE: 7779's Return on Equity (0.3%) is considered low.
How is CYBERDYNE's financial position?
Financial Position Analysis
Short Term Liabilities: 7779's short term assets (¥28.0B) exceed its short term liabilities (¥489.0M).
Long Term Liabilities: 7779's short term assets (¥28.0B) exceed its long term liabilities (¥3.1B).
Debt to Equity History and Analysis
Debt Level: 7779's debt to equity ratio (0.2%) is considered satisfactory.
Reducing Debt: 7779's debt to equity ratio has reduced from 72.7% to 0.2% over the past 5 years.
Debt Coverage: 7779's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 7779's interest payments on its debt are well covered by EBIT.
What is CYBERDYNE current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 7779's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 7779's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 7779's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 7779's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 7779's dividend in 3 years as they are not forecast to pay a notable one for the JP market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Yoshiyuki Sankai (62 yo)
Mr. Yoshiyuki Sankai has been the President and Chief Executive Officer of CYBERDYNE Inc. since February 2006 and also serves as its Chairman. Mr. Sankai established CYBERDYNE, Inc. in June 2004. He has be...
|Chairman||14.92yrs||no data||37.53% |
|Team Leader of Information Strategy Team & Director||16.58yrs||no data||no data|
|Head of Corporate Unit & Director||11.92yrs||no data||0.028% |
|Outside Audit & Supervisory Board Member||13.58yrs||no data||no data|
|Independent Outside Director||5.58yrs||no data||no data|
|Independent Outside Director||7.58yrs||no data||0.028% |
|Outside Audit & Supervisory Board Member||9.58yrs||no data||no data|
|Director||16.58yrs||no data||0.0065% |
|Independent Outside Director||12.58yrs||no data||no data|
|Outside Audit & Supervisory Board Member (Full-Time)||9.58yrs||no data||no data|
Experienced Board: 7779's board of directors are seasoned and experienced ( 11.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CYBERDYNE Inc.'s company bio, employee growth, exchange listings and data sources
- Name: CYBERDYNE Inc.
- Ticker: 7779
- Exchange: TSE
- Founded: 2004
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: JP¥138.548b
- Shares outstanding: 215.14m
- Website: https://www.cyberdyne.jp
Number of Employees
- CYBERDYNE Inc.
- 2-2-1, Gakuen-Minami
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|7779||TSE (The Tokyo Stock Exchange)||Yes||Common Shares||JP||JPY||Mar 2014|
|8C4||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Mar 2014|
|CYBQ.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Mar 2014|
|CYBQ.Y||OTCPK (Pink Sheets LLC)||SPONSORED ADR||US||USD||Oct 2015|
CYBERDYNE Inc. manufactures and sells medical devices in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use for people who have disorders in the lower limb and leg weaknesses, as well as...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/20 08:08|
|End of Day Share Price||2021/01/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.